TrialClinical pharmacology and therapeutics2025

Exposure-Response Analyses of Sacituzumab Govitecan Efficacy and Safety in Patients With Metastatic Triple-Negative Breast Cancer.

Abhishek G Sathe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.